Original Research
Published on 06 Apr 2021
Economic Evaluation of First-Line Atezolizumab for Extensive-Stage Small-Cell Lung Cancer in the US
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2021.650392
- 7,129 views
- 19 citations
